Prescribing Paxlovid (nirmatrelvir and ritonavir) for COVID-19

You are invited to attend a live training session (two sessions available, see times below) for Saskatchewan community prescribers to familiarize themselves with the prescribing requirements for publicly-funded Paxlovid™ treatment for early Covid-19.  You must register for one of these sessions to attend live and/or to receive a recording.

Target Audience: While these sessions are meant to support community prescribers for Paxlovid™ for COVID-19, all Saskatchewan health care providers are invited to attend.

Accredited by CPDPP: for 1.5 CEUs

Speakers: Kirsten Bazylak, BSP, medSask/CPDPP
                  Dr. S. Takaya, MD, FRCPC, Infectious Disease
                  Dr. S. Lee, MD, FRCPC, Internal Medicine and Infectious Disease

Learning Objectives:
At the end of the training, participants will be able to:

  1. Understand patient assessment and prescribing process requirements for community prescribing of Paxlovid™ for mild COVID-19.
  2. Identify patients requiring referral and describe the referral process to ensure timely access to care.
  3. Outline Saskatchewan guidance on drug interactions and how to manage at a community prescriber level.
  4. Locate helpful resources and additional supports for Paxlovid™.
  5. Share experiences and insights from experts working in infectious disease and treatment of early COVID-19.

Recording Link for: Prescribing Paxlovid™ (nirmatrelvir and ritonavir) for COVID-19

(You will be asked to register to view the recording).

Note for recordings:
The College of Family Physicians of Canada: Family physicians may claim up to 1.5 non-certified Mainpro+ Self-Learning credits.

Royal College of Physicians and Surgeons of Canada: Participants are reminded that the 1.5 hours of video presentations are a valuable source of Section 2 Credits in the MOC framework Self-Learning. Video, audio or Podcast learning activities can be claimed for 0.5 credits per activity.